Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Metamizole vs Ibuprofen and Education in Low Back Pain
NCT04111315Phase 4Recruiting
- Sponsor
- Insel Gruppe
- Start
- Dec 2019
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Metamizole sodium in low back pain (LBP) (4 arms), sponsored by Insel Gruppe. Primary endpoints: Change from baseline pain on the numeric rating scale (NRS) at 14 days and Change from baseline Core Outcome Measures Index (COMI) sum-score at 42 days. Started Dec 2019; status: recruiting.
02
Drugs
Metamizole sodium
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT04111315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04111315.